Prevalence and outcome of epidermal growth factor receptor mutations in non-squamous non-small cell lung cancer patients

Abstract

This study from India, further establishes the importance of upfront EGFR mutation testing in all NS-NSCLC patients, not only to prognosticate, but also to identify that subset of patients who could benefit from EGFR TKI therapy, early in the course of their disease.